| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 7,574,000 | 7,000,000 | 6,684,000 | 6,713,000 | | Cost of Revenue | 8,490,000 | 6,031,000 | 6,122,000 | 6,964,000 | | | Gross Profit | (916,000) | 969,000 | 562,000 | (251,000) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | (482,000) | 527,000 | 562,000 | (515,000) | | Non Recurring | 129,000 | 58,000 | 99,000 | 987,000 | | Others | (767,000) | 383,000 | 384,000 | 374,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 204,000 | 1,000 | (483,000) | (1,097,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (64,000) | 70,000 | (3,000) | (64,000) | | Earnings Before Interest And Taxes | 140,000 | 71,000 | (486,000) | (1,161,000) | | Interest Expense | 319,000 | 324,000 | 308,000 | 277,000 | | Income Before Tax | (179,000) | (253,000) | (794,000) | (1,438,000) | | Income Tax Expense | (18,000) | 4,000 |
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (161,000) | (257,000) | (794,000) | (1,438,000) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (161,000) | (257,000) | (794,000) | (1,438,000) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($161,000) | ($257,000) | ($794,000) | ($1,438,000) |
|
1.48% Nasdaq 
0.02 (0.25%) 
Income Statement
